Article
Clinical use of polygenic risk scores: current status, barriers and future directions.
Nature reviews. Genetics - 1 Mar 2026
Kullo Iftikhar J
Abstract excerpt
Genome-wide association studies have identified thousands of single-nucleotide variants that are associated with complex traits, including cardiometabolic diseases, cancers and neurological disorders. Polygenic risk scores (PRSs), which aggregate the effects of these variants, can help to identify individuals who are at increased risk of developing such diseases. As PRSs are typically only weakly associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
